Nephroceuticals is a leading global manufacturer of scientifically-based nutritional supplements specifically designed to address nutritional deficiencies in patients with Chronic Kidney Disease, Cardiovascular Disease, and Inflammatory Bowel Disease. The company's products adhere to the highest quality standards and FDA certified manufacturing guidelines, ensuring reliability and trust in their offerings. Nephroceuticals has established strategic partnerships with prominent clinical experts and institutions such as the National Kidney Foundation, the American Association of Heart Failure Nurses, and the Crohn’s and Colitis Foundation to validate and endorse their products. Since its founding in 2008, Nephroceuticals has carved a niche as the 'Leaders in Kidney, Heart & IBD Health Multivitamins', positioning itself as a prominent player in the health and wellness industry. While specific details regarding recent investments or headquarters are not available, the company's commitment to addressing critical health issues and collaborating with leading experts positions it as an appealing prospect for potential investors seeking opportunities in the health and wellness sector.
There is no investment information
No recent news or press coverage available for Nephroceuticals.